Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Toma

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Cancer Investigation|January 8, 2011
Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinomaMarieta I Toma, Thomas Weber, Matthias Meinhardt, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2005
Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinomaMartin G Friedrich, Shahin Chandrasoma, Kimberly D Siegmund, et al.
Neoplasia (New York, N.Y.)|July 2, 2008
Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping arrayMarieta I Toma, Marianne Grosser, Alexander Herr, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|July 14, 2011
Effects of perfusion and cyclic compression on in vitro tissue engineered meniscus implantsM Petri, K Ufer, I Toma, et al.
Genes, Chromosomes & Cancer|November 6, 2012
PARK2 and PACRG are commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcomeMarieta I Toma, Daniela Wuttig, Sandy Kaiser, et al.
Advances in Experimental Medicine and Biology|January 2, 2020
Quantification of Tumor Oxygenation Based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference RegionM Lazzeroni, I Toma-Dasu, A Ureba, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|December 17, 1998
[The postoperative monitoring of intracranial pressure in patients in the acute period of aneurysmatic hemorrhage]Sh Sh Eliava, K G Oganesian, A A Dausheva, et al.
Cytotherapy|December 12, 2024
FTY720P-treated macrophages in PEG-4MAL hydrogels promote oral wound healingAndre J Burnham, Afra I Toma, Daniel Shah, et al.
Angewandte Chemie (International Ed. in English)|March 17, 2025
Immunoengineering of a Photocaged 5´-triphosphate Oligoribonucleotide Ligand for Spatiotemporal Control of RIG-I Activation in CancerSandra Anika Lewash, Vivien Rose McKenney, Christine Wuebben, et al.
International Journal of Cancer|January 4, 2012
CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastasesDaniela Wuttig, Stefan Zastrow, Susanne Füssel, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Cancer Investigation|January 8, 2011
Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinomaMarieta I Toma, Thomas Weber, Matthias Meinhardt, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2005
Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinomaMartin G Friedrich, Shahin Chandrasoma, Kimberly D Siegmund, et al.
Neoplasia (New York, N.Y.)|July 2, 2008
Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping arrayMarieta I Toma, Marianne Grosser, Alexander Herr, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|July 14, 2011
Effects of perfusion and cyclic compression on in vitro tissue engineered meniscus implantsM Petri, K Ufer, I Toma, et al.
Genes, Chromosomes & Cancer|November 6, 2012
PARK2 and PACRG are commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcomeMarieta I Toma, Daniela Wuttig, Sandy Kaiser, et al.
Advances in Experimental Medicine and Biology|January 2, 2020
Quantification of Tumor Oxygenation Based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference RegionM Lazzeroni, I Toma-Dasu, A Ureba, et al.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko|December 17, 1998
[The postoperative monitoring of intracranial pressure in patients in the acute period of aneurysmatic hemorrhage]Sh Sh Eliava, K G Oganesian, A A Dausheva, et al.
Cytotherapy|December 12, 2024
FTY720P-treated macrophages in PEG-4MAL hydrogels promote oral wound healingAndre J Burnham, Afra I Toma, Daniel Shah, et al.
Angewandte Chemie (International Ed. in English)|March 17, 2025
Immunoengineering of a Photocaged 5´-triphosphate Oligoribonucleotide Ligand for Spatiotemporal Control of RIG-I Activation in CancerSandra Anika Lewash, Vivien Rose McKenney, Christine Wuebben, et al.
International Journal of Cancer|January 4, 2012
CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastasesDaniela Wuttig, Stefan Zastrow, Susanne Füssel, et al.
Pageof 6